VAERS reports by lot

GSK DTaP/Tdap lot 7D2Y4: VAERS reports

34 VAERS reports list lot 7D2Y4 as a GSK DTaP/Tdap vaccine, received between 2023-08-02 and 2024-11-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
34
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)533%
Injection-site / Local reaction427%
Neurological213%
Allergic / Anaphylactic213%
Gastrointestinal17%
General / Systemic (non-local)17%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan6
Texas5
Pennsylvania4
Tennessee2
Missouri2
Maine2
Arkansas2
Oklahoma1
California1
Illinois1
Utah1
Wisconsin1

Reports by month received

2023-083
2023-092
2023-103
2023-113
2023-122
2024-012
2024-023
2024-033
2024-041
2024-054
2024-061
2024-072
2024-081
2024-091
2024-101
2024-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.